Fish delivers protein, and when you choose a fatty fish like tuna, salmon or trout, you're also getting omega-3 fatty acids.

To identify kidney disease early, screening is essential. “If we screen for kidney disease in the context of diabetes, ...

In patients with type 2 diabetes, the risk for chronic kidney disease differed among users of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylurea.

If approved, Fabhalta® will be the only medicine indicated to selectively target the underlying cause of C3G1, an ultra-rare, progressive kidney disease with no currently approved treatments2-5 Phase ...

Fabhalta (iptacopan) is an oral, Factor B inhibitor of the alternative complement pathway 6-7.

China: A recent prospective study has highlighted the role of fibroblast growth factor 23 (FGF23) as an early biomarker for ...

SGLT2 inhibitors reduce the risk of kidney failure in patients with Type 2 diabetes and advanced chronic kidney disease, ...

Patients with CKD have a 56% higher prevalence of severe mental health disorders such as schizophrenia, bipolar disorder, or ...

The five stages of chronic kidney disease (CKD) indicate how well the kidneys are working, ranging from stage 1 (mild kidney ...

Weight fluctuation was associated with a greater risk for diabetic kidney disease progression among individuals with type 1 diabetes.

China: The researchers have developed a predictive model to assess the progression of diabetic kidney disease (DKD) to ...

Vitamin D deficiency (VDD) is independently associated with increased depression risk in patients with chronic kidney disease ...